Stockreport

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]

Calidi Biotherapeutics, Inc.  (CLDI) 
PDF biotechnology company developing a new generation of targeted immunotherapies, today announced that it has entered into a definitive securities purchase agreement with a [Read more]